High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy

Neuromuscular Disorders

Volumn 12, Issue 10, 2002, Pages 917-925

  Connolly, Anne M ^a   Schierbecker, Jeanine ^a   Renna, Renee ^a   Florence, Julaine ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Contracture; Duchenne muscular dystrophy; Obesity; Prednisone

Indexed keywords

PREDNISONE; ANTIINFLAMMATORY AGENT;

ARM MUSCLE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FOLLOW UP; HUMAN; IMMOBILIZATION; IRRITABILITY; MALE; MANOMETER; MUSCLE CONTRACTURE; MUSCLE STRENGTH; OBESITY; PARALYSIS; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; SLEEP DISORDER; STEROID THERAPY; TREATMENT OUTCOME; ARM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DUCHENNE MUSCULAR DYSTROPHY; HAND GRIP; LEG; LONGITUDINAL STUDY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; STANDARD; TIME;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; HAND STRENGTH; HUMANS; LONGITUDINAL STUDIES; LOWER EXTREMITY; MALE; MUSCULAR DYSTROPHY, DUCHENNE; OBESITY; PREDNISONE; TIME FACTORS; TREATMENT OUTCOME; UPPER EXTREMITY; WEIGHTS AND MEASURES;

EID: 0036893708     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00180-3     Document Type: Article

References (25)

1. Drachman D.B., Toyka K.V., Myer E. Prednisone in Duchenne muscular dystrophy. Lancet. 2:(7894):1974;1409-1412.
2. Brooke M.H., Fenichel G.M., Griggs R.C., et al. Clinical investigation of Duchenne muscular dystrophy; interesting results in a trial of prednisone. Arch Neurol. 44:1987;812-817.
3. DeSilva S., Drachman D.B., Mellits D., Kuncl R.W. Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Arch Neurol. 44:(8):1987;818-822.
4. Mendell J.R., Moxley R.T., Griggs R.C., et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med. 320:1989;1592-1597.
5. Fenichel G.M., Mendell J.R., Moxley R.T., et al. A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. Arch Neurol. 48:1991;575-579.
6. Griggs R.C., Moxley R.T., Mendell J.R., et al. Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months). Neurology. 43:1993;520-527.
7. Fenichel G.M., Florence J.M., Pestronk A., et al. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology. 41:1991;1874-1877.
8. Angelini C., Pegoraro E., Turella E., Intino M.T., Pini A., Costa C. Deflazacort in Duchenne dystrophy: study of long-term effect. Muscle Nerve. 17:(4):1994;386-391. [published erratum appears in Muscle Nerve 1994 Jul;17(7):833].
9. Sansome A., Royston P., Dubowitz V. Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule. Neuromuscul Disord. 3:(5-6):1993;567-569.
10. Angelini C., Bonifati M., Dubowitz V., et al. 47th ENMC International Workshop: treatment of muscular dystrophy. 13-15 December 1996, Naarden, The Netherlands. Neuromuscul Disord. 7:(4):1997;261-267.
11. Dubowitz V. 75th European Neuromuscular Centre International Workshop: 2nd workshop on the treatment of muscular dystrophy 10-12 December, 1999, Naarden, The Netherlands. Neuromuscul Disord. 10:(4-5):2000;313-320.
12. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med. 333:1995;832-838.
13. Chez M.G., Loeffel M., Buchanan C., Field-Chez M. Pulse high dose steroids as combination therapy with valproic acid in epileptic aphasia patients with pervasive developmental delay or autism. Ann Neurol. 44:1998;539.
14. Chez MG, Buchanan C, Loeffel M. Practical treatment with pulse-dose corticosteroids in pervasive developmental delay or autisitc patients with abnormal epileptiform sleep EEG and language delay. In: Monduzzi, editor. New developments in child neurology. Proceedings of the 8th World Congress of Child Neurology. Bologna, Italy: 1998. p. 695-8.
15. Buchanan C.P., Chez M.G., Nowinski C. Pulse-dose steroids as add-on therapy in patients with pediatric epilepsy. Epilepsia. 41S:1998;183.
16. Nevo Y., Pestronk A., Lopate G., Carroll S.L. Neuropathy of metachromatic leukodystrophy: improvement with immunomodulation. Pediatr Neurol. 15:1996;237-239.
17. Connolly A.M., Pestronk A., Mehta S., Al-Lozi M. Case of the month: Primary a-sarcoglycan deficiency responsive to immunosuppression over three years. Muscle Nerve. 21:1998;1549-1553.
18. Escolar D.M., Henricson E.K., Mayhew J., et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve. 24:(6):2001;787-793.
19. Hamill P.V., Drizd T.A., Johnson C.L., Reed R.B., Roche A.F., Moore W.M. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr. 32:(3):1979;607-629.
20. Larson C.M., Henderson R.C. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop. 20:(1):2000;71-74.
21. Dubowitz V., Kinali M., Main M., Mercuri E., Mutoni F. Remission of clinical signs in early duchenne muscular dystrophy on inermittent low-dosage prednisolone therapy. Eur J Paediatr Neurol. 6:2002;153-159.
22. Kissel J.T., Lynn D.J., Rammohan K.W., et al. Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy. Neurology. 43:1993;532-536.
23. Emslie-Smith A.M., Arahata K., Engel A.G. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol. 20:(3):1989;224-231.
24. Engel A.G., Biesecker G. Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers. Ann Neurol. 12:(3):1982;289-296.
25. Engel A.G., Yamamoto M., Fischbeck K.H. Dystrophinopathies. Engel A.G., Franzini-Armstrong C. Myology. 1994;1133-1187 McGraw-Hill, New York, NY.